Post by
Canny321 on Sep 29, 2014 9:50am
Facility comparison - bed in lead
Bedrocan has been focused on patient acquisition = they have more then twd, ogi or tpi combined. They may be less focused on pr but that may be due to them focusing their efforts for time being on having by end of year the largest local facility of actual production ready - tweed hoped to have 10k sq foot of their massive facility done by end of August - their 470,000 number is an illusion. Ogi has less than 15k sq foot and haven't been proven. Tpi can do 300 patients. Bedrocan will be able to handle 10k patients in their fully complete facility of 52k. Plus will be paid for in full. Bedrocan is lowest production risk out of all producers given decade of experience and European team moving here to run - don't be scared with mettrum too as they have current 15k facility which can handle a few hundred kilo a year and they haven't started on 2nd facility yet IMO
Comment by
frankie1122 on Sep 30, 2014 8:53pm
This post has been removed in accordance with Community Policy